Back to Search
Start Over
Use of Cold Atmospheric Plasma in the Treatment of Squamous Cell Carcinoma: in vitro Effects and Clinical Application in Feline Tumors: A Pilot Study.
- Source :
-
Topics in companion animal medicine [Top Companion Anim Med] 2023 Mar-Jun; Vol. 53-54, pp. 100773. Date of Electronic Publication: 2023 Mar 27. - Publication Year :
- 2023
-
Abstract
- Cold atmospheric plasma (CAP) has shown promising results against squamous cell carcinoma (SCC) in both in vivo and in vitro assays, mainly in humans and mice. Its applicability for treatment of feline tumors, however, remains unknown. This study aimed to evaluate the anticancer effects of CAP on a head and neck squamous cell carcinoma (HNSCC) cell lineage and against a clinical case of cutaneous SCC in a cat. Control and treatment groups employing the HNSCC cell line (SCC-25) were used, the latter exposed to CAP for 60 seconds, 90 seconds, or 120 seconds. The cells were subjected to the MTT assay nitric oxidation assay and thermographic in vitro analyses. The clinical application was performed in one cat with cutaneous SCC (3 sites). The lesions were treated and evaluated by thermographic, histopathological, and immunohistochemical examinations (caspase-3 and TNF-alpha). Treatment of the SCC-25 cells for 90 seconds and 120 seconds resulted in a significant nitrite concentration increase. Decreased cell viability was observed after 24 hours and 48 hours, regardless of exposure time. However, the cell viability reduction observed at 72 hours was significant only in the 120 seconds treatment. In vitro, the temperature decreased for all treatment times, while the plasma induced a slight increase in mean temperature (0.7°C) in the in vivo assay. Two of the 3 clinical tumors responded to the treatment: one with a complete response and the other, partial, while the third (lower lip SCC) remained stable. Both remaining tumors displayed apoptotic areas and increased expression of caspase-3 and TNF-alpha. Adverse effects were mild and limited to erythema and crusting. The CAP exhibited an in vitro anticancer effect on the HNSCC cell line, demonstrated by a dose-dependent cell viability reduction. In vivo, the therapy appears safe and effective against feline cutaneous SCC. The treatment did not result in a clinical response for 1 of 3 lesions (proliferative lower lip tumor), however, a biological effect was still demonstrated by the higher expression of apoptosis indicators.<br /> (Copyright © 2023 Elsevier Inc. All rights reserved.)
- Subjects :
- Humans
Cats
Animals
Mice
Squamous Cell Carcinoma of Head and Neck veterinary
Caspase 3
Pilot Projects
Tumor Necrosis Factor-alpha
Cell Line, Tumor
Head and Neck Neoplasms therapy
Head and Neck Neoplasms veterinary
Plasma Gases therapeutic use
Plasma Gases pharmacology
Carcinoma, Squamous Cell drug therapy
Carcinoma, Squamous Cell veterinary
Cat Diseases therapy
Subjects
Details
- Language :
- English
- ISSN :
- 1946-9837
- Volume :
- 53-54
- Database :
- MEDLINE
- Journal :
- Topics in companion animal medicine
- Publication Type :
- Academic Journal
- Accession number :
- 36990177
- Full Text :
- https://doi.org/10.1016/j.tcam.2023.100773